Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021
During the study period, we observed a five-fold decline in opioid dose prescribed by oncologists for cancer pain. This raises concerns for undertreatment of pain in patients with cancer.
Authors
- Ali A. Rizvi (ORCID: https://orcid.org/0000-0002-3714-0790)
- Patricia Bramati (ORCID: https://orcid.org/0000-0001-7068-7045)
- David Hui (ORCID: https://orcid.org/0000-0003-2733-6607)
- Eduardo D Bruera (ORCID: https://orcid.org/0000-0002-8745-0412)
- Aline Rozman de Moraes (ORCID: https://orcid.org/0000-0002-7047-4792)
- Bryan Fellman (ORCID: https://orcid.org/0000-0002-1810-5762)
- Ali Haider (ORCID: https://orcid.org/0000-0003-3323-8595)
- Sonal Admane (ORCID: https://orcid.org/0000-0002-1616-5462)
- Annie Berly
- Evelin Kolenc
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1200/op-24-00782
- Citations
- 7
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 15.34